Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell diseaseAjeet Singh, Aymar Akilimali, Zainab Nazir et al.|Annals of Medicine and Surgery|2024Cited by 87
Impacts of the advancement in artificial intelligence on laboratory medicine in low‐ and middle‐income countries: Challenges and recommendations—A literature reviewMalik Olatunde Oduoye, Emmanuel Ebuka Elebesunu, Godfred Yawson Scott et al.|Health Science Reports|2024Cited by 62
Falls among older adults in Nigeria; public health implications and preventive measuresMalik Olatunde Oduoye, Samuel Chinonso Ubechu, A Adedayo et al.|International Journal of Surgery Global Health|2023Cited by 4
“Is sotagliflozin a ‘wonder drug’? A review of its impact on cardiovascular, diabetic, renal, neuroprotective, and hepatic outcomes”Eeshal Fatima, Aymar Akilimali, Faiza Fatima et al.|Annals of Medicine and Surgery|2025Cited by 4